1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Lymphocytic: new trials by email Literature Review of Lymphocytic trials Research Report on Lymphocytic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia rhIL-15, Obinutuzumab - Leukemia, Lymphocytic | Phase 1 | Terminated | National Cancer Institute (NCI) | 1 | 2019-07-11 | 2022-03-22 |
| A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer PCI-24781 - Lymphoma, Non-Hodgkin's Lymphoma | Phase 1 | Completed | Pharmacyclics LLC. | 7 | 2010-06-01 | 2013-06-19 |
Bronchiolitis Obliterans Syndrome (2) · Leukemia (2) · Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1)
Bronchial Diseases (2) · Bronchiolitis (2) · Bronchiolitis Obliterans (2) · Bronchitis (2) · Graft vs Host Disease (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Organizing Pneumonia (2) · Respiratory Tract Diseases (2) · Blood Protein Disorders (1)
Interleukin-15 (1) · abexinostat (1) · obinutuzumab (1)
National Cancer Institute (NCI) (1) · Pharmacyclics LLC. (1)
United States (2)
Kevin C Conlon, M.D. (1) · Thorsten Graef, MD (1)